SCHEMBL3129781

SCHEMBL3129781

CC(CCl)C(=O)c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 1/20 0.52
ADRA2A P08913 1/20 0.52
ADRA2B P18089 1/20 0.52
HTR2A P28223 1/20 0.52
HRH1 P35367 1/20 0.52
KCNH2 Q12809 1/20 0.52
LMNA P02545 8/20 0.49
ALDH1A1 P00352 6/20 0.49
MAPK1 P28482 3/20 0.48
TRPA1 O75762 1/20 0.48
GSK3B P49841 1/20 0.48
HIF1A Q16665 1/20 0.48
MDM2 Q00987 1/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
TDP1 Q9NUW8 2/20 0.47
KMT2A Q03164 2/20 0.46
SMN1; SMN2 Q16637 5/20 0.46
TP53 P04637 1/20 0.46
CES1 P23141 2/20 0.45
CES2 O00748 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2736658 1.00 PGR (0.52) PGRADRA2AADRA2BHTR2AHRH1
SCHEMBL2736657 1.00 PGR (0.52) PGRADRA2AADRA2BHTR2AHRH1
SCHEMBL3128781 0.91 PGR (0.49) PGRADRA2AADRA2BHTR2AHRH1
SCHEMBL11151429 0.84 PARP10 (0.50) ALDH1A1SMN1; SMN2
SCHEMBL11230623 0.84 PGR (0.49) PGRADRA2AADRA2BHTR2AHRH1
SCHEMBL11574087 0.82 CHRM2 (0.54) ADRA2BLMNAALDH1A1GSK3BTDP1
SCHEMBL2736655 0.81 L3MBTL1 (0.54) PGRADRA2AADRA2BHTR2AHRH1
SCHEMBL2736656 0.81 L3MBTL1 (0.54) PGRADRA2AADRA2BHTR2AHRH1
SCHEMBL14665678 0.81 PGR (0.53) PGRADRA2AADRA2BHTR2AHRH1
SCHEMBL2128162 0.81 PGR (0.58) PGRADRA2AADRA2BHTR2AHRH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101619056-B Benzothiophene alkanol piperazine derivatives and use thereof as antidepressant medicaments SHANGHAI INST PHARM INDUSTRY 2013-07-17 CN disclosed
EP-1256569-B1 PHENACYLAMINE DERIVATIVES, PRODUCTION THEREOF AND PEST CONTROLLERS CONTAINING THE DERIVATIVES ISHIHARA SANGYO KAISHA (JP) 2010-07-07 EP disclosed
CN-101619056-A Benzothiophene alkanol piperazine derivatives and use thereof as antidepressant medicaments ZHONGQI PHARMACEUTICAL TECHNOLOGY SHIJIAZHUANG CO LTD 2010-01-06 CN disclosed
US-7439366-B2 Phenacylamine derivatives, process for their production and pesticides containing them ISHIHARA SANGYO KAISHA LTD. (JP) 2008-10-21 US disclosed
US-20030153464-A1 Phenacylamin derivatives, production thereof and pest controllers containing the derivatives ISHIHARA SANGYO KAISHA LTD. (JP) 2003-08-14 US disclosed
EP-1256569-A1 PHENACYLAMINE DERIVATIVES, PRODUCTION THEREOF AND PEST CONTROLLERS CONTAINING THE DERIVATIVES ISHIHARA SANGYO KAISHA, LTD. (JP) 2002-11-13 EP disclosed
US-5179229-A Preparation of 2,2-diorgano-3-arylpropionic acids and esters thereof HOECHST CELANESE CORPORATION (US) 1993-01-12 US disclosed
US-RE30634-E INSECTICIDES SHELL OIL COMPANY (US) 1981-06-02 US disclosed
US-4108897-A Benzylhydroxylamine ethers SHELL OIL COMPANY (US) 1978-08-22 US disclosed
US-4079149-A INSECTICIDES SHELL OIL COMPANY (US) 1978-03-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030153464-A1 Phenacylamin derivatives, production thereof and pest controllers containing the derivatives SCN4A, NAT1, HCN4 PGR 3672/4885ADRA2A 688/4885ADRA2B 617/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.